Challenges of Target/Compound Data Integration from Disease to Chemistry: A Case Study of Dihydrofolate Reductase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|2|2|75-87

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.2, Iss.2, 2005-06, pp. : 75-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dihydrofolate Reductase as a Target for Chemotherapy in Parasites

By  

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 609-639

Bentham Science Publishers

Access to resources Recommend Favorite

Novel inhibitors of Trypanosoma cruzi dihydrofolate reductase

By Zuccotto F.   Zvelebil M.   Brun R.   Chowdhury S.F.   Di Lucrezia R.   Leal I.   Maes L.   Ruiz-Perez L.M.   Gonzalez Pacanowska D.   Gilbert I.H.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 5, 2001-05 ,pp. : 395-405

Elsevier

Access to resources Recommend Favorite

Dihydrofolate reductase inhibitors: new developments in antiparasitic chemotherapy

By Savel Jean   Durand Rémy  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1285-1290

Informa Healthcare

Access to resources Recommend Favorite

From Polypharmacology to Target Specificity: The Case of PARP Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 23, 2013-12 ,pp. : 2939-2954

Bentham Science Publishers

Access to resources Recommend Favorite

Topomer CoMFA 3D-QSAR and Docking Studies of Pyrimidine Inhibitors of Pneumocystis Carinii Dihydrofolate Reductase

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 10, 2016-12 ,pp. : 1055-1062

Bentham Science Publishers

Access to resources Recommend Favorite